NeoMPS gets acquired
PolyPeptide Laboratories Group is to acquire the peptide manufacturing group NeoMPS.
PolyPeptide Laboratories Group is to acquire the peptide manufacturing group NeoMPS.
After a clinical hiccough five months ago set Coley Pharmaceutical's drug development funding back several years, Pfizer has stepped in to save the day, snapping up the biotech for $164m.
Contract pharmaceutical development company Azopharma has carved out its drug delivery segment into a new company, APIcross Drug Delivery Technologies.
Celgene has agreed to pay $2.9bn for Pharmion in the hope of becoming a 'global leader in the haematology and oncology field', but do the company's pipelines match up well together?
Workers at Johnson & Johnson's (J&J's) Belgium subsidiary went on strike today in protest at the compensation being offered to those at the firm falling foul of the dreaded pharma axe.